CWICX
Price
$79.81
Change
-$0.98 (-1.21%)
Updated
Jul 13 closing price
Net Assets
157.74B
GCEAX
Price
$18.41
Change
-$0.14 (-0.75%)
Updated
Jul 13 closing price
Net Assets
1.41B
Interact to see
Advertisement

CWICX vs GCEAX

CWICX vs GCEAX Comparison Chart in %
View a ticker or compare two or three
VS
CWICX vs. GCEAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWICX is a Buy and GCEAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWICX has more cash in the bank: 158B vs. GCEAX (1.41B). CWICX pays higher dividends than GCEAX: CWICX (0.66) vs GCEAX (0.56). CWICX was incepted earlier than GCEAX: CWICX (24 years) vs GCEAX (12 years). CWICX (1.52) is less costly to investors than GCEAX (1.03). GCEAX is a more actively managed with annual turnover of: 67.00 vs. CWICX (44.00). CWICX has a lower initial minimum investment than GCEAX: CWICX (250) vs GCEAX (2500). CWICX annual gain was more profitable for investors over the last year : 13.22 vs. GCEAX (-2.16). CWICX return over 5 years is better than : 28.73 vs. GCEAX (7.20).
CWICXGCEAXCWICX / GCEAX
Total Expense Ratio1.521.03148%
Annual Report Gross Expense Ratio1.521.03148%
Fund Existence24 years12 years-
Gain YTD12.7555.578229%
Front LoadN/A4%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets158B1.41B11,182%
Annual Yield % from dividends0.660.56116%
Returns for 1 year13.22-2.16-613%
Returns for 3 years40.8123.99170%
Returns for 5 years28.737.20399%
Returns for 10 years97.6292.30106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSAKX23.77N/A
N/A
Goldman Sachs International Eq Inc A
LMCQX37.32N/A
N/A
Lord Abbett Mid Cap Stock R2
MCEIX20.93N/A
N/A
ClearBridge Emerging Markets I
TRPIX55.45N/A
N/A
T. Rowe Price Value I
SBASX14.94N/A
N/A
Segall Bryant &Hamill Small Cap Cre Ins